North America / UNITED STATES
Company Overview
Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company was founded on December 23, 2014 and is headquartered in North Chesterfield, VA.
Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company was founded on December 23, 2014 and is headquartered in North Chesterfield, VA.
Includes quarterly earnings and dividends.
Company Details
| Major Industry | Pharmaceuticals & Biotechnology |
| Sub Industry | Pharmaceutical Preparations |
| Country | UNITED STATES |
| Employees | 838 |
| Reporting Unit | Millions |
| Primary Exchange | NYSE NAS ASE DUS FRA LON MXK BLN |
| Instrument Type | Equity |
| Website | indivior.com |
| Wright ID | C840NS30T |
Key Metrics
| Current price | $36.28 |
| Market cap | $4.53 B |
| P/E ratio | 10.04 |
| 52-week perf. | +23.5% |
| Common shares | 124.8 M |
| Closely held | 7.7 M |
| Share type | Ordinary |
| Quality rating | BBD13 |
| Dividend yield | 0.00% |
Recent stock performance
| 1 Week | +2.6% |
| 4 Week | +1.6% |
| 13 Week | -9.3% |
Officers
n/a
Address
234 BATH ROAD
SLOUGH, BERKSHIRE
UNITED STATES
SL1 4EE
| Phone | n/a |
Quarterly Earnings & Dividends
Quarterly earnings and dividend history is not available for this company.
Try another report for annual statements, Wright Quality history or comparative analysis.